Escitalopram: A New SSRI for the Treatment of Depression in Primary Care
Escitalopram is the S-enantiomer of the racemic compound citalopram, a selective serotonin reuptake inhibitor (SSRI) widely used for the treatment of depression. This review describes the current body of pharmacologic and clinical evidence supporting the use of escitalopram for the treatment of depr...
Guardat en:
| Publicat a: | Prim Care Companion J Clin Psychiatry |
|---|---|
| Autor principal: | |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Physicians Postgraduate Press, Inc.
2002
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC315490/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/15014711/ https://ncbi.nlm.nih.govhttps://doi.org/10.4088/pcc.v04n0601 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|